Rate of development of clinical definite multiple sclerosis 10 years [clinicaltrials_resource:4aecbcd63ce5efa352a97670acbc1eaf]
Initiation of treatment with Interferon Beta 1a IM once weekly immediately after onset of a first demyelinating syndrome in high risk individuals
clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]
Rate of development of clinical definite multiple sclerosis 10 years [clinicaltrials_resource:4aecbcd63ce5efa352a97670acbc1eaf]
Initiation of treatment with Interferon Beta 1a IM once weekly immediately after onset of a first demyelinating syndrome in high risk individuals
Bio2RDF identifier
4aecbcd63ce5efa352a97670acbc1eaf
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:4aecbcd63ce5efa352a97670acbc1eaf
measure [clinicaltrials_vocabulary:measure]
Rate of development of clinical definite multiple sclerosis
time frame [clinicaltrials_vocabulary:time-frame]
description
Initiation of treatment with I ...... drome in high risk individuals
identifier
clinicaltrials_resource:4aecbcd63ce5efa352a97670acbc1eaf
title
Rate of development of clinical definite multiple sclerosis 10 years
@en
type
label
Rate of development of clinica ...... cbcd63ce5efa352a97670acbc1eaf]
@en